Get startedLog in
    Picture of bluebird bio logo

    BLUE — bluebird bio Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for bluebird bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    C2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:10-K10-K10-K10-K10-K
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-619-819-230-212-241
    Depreciation
    Non-Cash Items158146-14.4-3.5559.2
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-28.918-79.8-48.1-140
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Other Liabilities
    Net Change in Other Assets & Liabilities
    Cash from Operating Activities-470-636-316-235-260
    Capital Expenditures-29-23-13.2-9.06-2.6
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-55.45862641646.5
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Cash from Investing Activities-84.35632501553.9
    Financing Cash Flow Items—-17402.5299.4
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities547-9417.519687.5
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-7.98-167-48.2116-169